Status:
UNKNOWN
Breather Trainer Versus Pulmonary Rehabilitation on Cardiopulmonary Efficiency
Lead Sponsor:
Horus University
Conditions:
COVID-19
COPD
Eligibility:
All Genders
30-40 years
Phase:
NA
Brief Summary
The purpose of the study is to determine the difference between The Breather respiratory muscle trainer and pulmonary rehabilitation in patients with COPD post COVID-19.
Detailed Description
The main concern in post COVID-19 patients is the involvement of respiratory system and cardiovascular system which may result in dyspnea, low blood oxygen saturation, and decrease cardiopulmonary eff...
Eligibility Criteria
Inclusion
- SPO2 ≥ 93%
- Their age ranges from 30-40 years old.
- COPD patients GOLD1 (Mild FEV1≥80% predicted) and GOLD2 (Moderate 50% ≤FEV1\<80%predicted) (Manian, 2019)
- patients diagnosed as post COVID-19 Pneumonia between 3 and 6 Months ago with CT scan and PCR testing.
- Their body mass index (BMI) ranged from 20 to 29.9kg/m2.
- Stable medical cases with dyspnea
Exclusion
- Patients who will meet one of the following criteria will be excluded from the study:
- patients with cardiac problems e.g. atrial fibrillation, left bundle-branch block, heart failure.
- Sever cases of COPD (FEV1/FVC\< 50%)
- Mitral or aortic valvular disease, pericardial effusion.
- Recent myocardial infarction.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05382780
Start Date
June 1 2022
End Date
November 15 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatient clinic, Faculty of Physical Therapy, Horus University, Egypt
Damietta, Egypt